Modulation of Immune Effector and Regulator Cells by Sunitinib: Potential for Combination Therapy in Renal Cell Carcinoma PatientsNo abstract available
Document ID
20150010410
Acquisition Source
Glenn Research Center
Document Type
Presentation
Authors
Finke, James (Cleveland Clinic Cleveland, OH, United States)
Rini, Brian (Cleveland Clinic Cleveland, OH, United States)
Ko, Jennifer (Cleveland Clinic Cleveland, OH, United States)
Rayman, Pat (Cleveland Clinic Cleveland, OH, United States)
Lindner, Dan (Cleveland Clinic Cleveland, OH, United States)
Borden, Ernie (Cleveland Clinic Cleveland, OH, United States)
Parsons-Wingerter, A. (NASA Glenn Research Center Cleveland, OH, United States)
Storkus, Walter (Paris VI Univ. France)
Cohen, Peter (Mayo Clinic Arizona, AZ, United States)
Date Acquired
June 10, 2015
Publication Date
June 11, 2012
Subject Category
Life Sciences (General)
Report/Patent Number
E-664232
Meeting Information
Meeting: Chemotherapy and the Immune Response in Cancer